Latest Blogs

Sep 16, 2021
Dr. Atlal Abusanad discusses how biases in valuing capability and potential in female oncologists has led to their underrepresentation in prominent roles. 
Sep 09, 2021
"I think of my fellowship studies as a series of layers—every time I do well at one layer, I am ready to move to the next one," said Dr. Tarek Haykal.
Sep 01, 2021
There has never been a more exciting time to be involved in cancer research, with so much knowledge to support our explorations and so many pressing questions still to answer.
Aug 25, 2021
"COVID-19 has taught us how we can both live in the present and focus on the future; how we can make the most out of our time, regardless of our physical condition," said Dr. Hilde M. Buiting.
Subscribe to this column

Don S. Dizon, MD, FACP, FASCO

Don S. Dizon, MD, FACP, FASCO, is a professor of medicine at Brown University, director of the Breast and Pelvic Malignancies Program and Hematology-Oncology Outpatient Clinics at Lifespan Cancer Institute, and director of Medical Oncology and the Sexual Health First Responders Clinic at Rhode Island Hospital. Dr. Dizon has served as past chair of ASCO's Social Media Working Group and the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the JCO Oncology Practice Editorial Board, and editor in chief of the ASCO Educational BookFollow Dr. Dizon across social media channels @drdonsdizon. 

Disclosure.

Jul 11, 2019
Consensus among a multidisciplinary team may not be easy, but it is, ultimately, the goal. That, in and of itself, is the definition of quality care.
May 16, 2019
My patient had struggled emotionally throughout the course of her cancer treatment, until the day I walked into the room and noticed a profound change.
Apr 23, 2019
The patients we mentally label as "difficult" are perhaps the ones who need our empathy the most.
Mar 28, 2019
The obstacles I faced in becoming a parent are not the ones faced by young breast cancer survivors and co-survivors, but I certainly understand the feeling of wanting children but fearing it wouldn’t happen.
Feb 21, 2019
I try to be clear when my approach is a recommendation based on the best data we have, and when it’s a suggestion in situations where reasonable clinicians may come to a different conclusion.
Jan 29, 2019
Immunotherapy—particularly immune checkpoint inhibition—is still experimental. It ends up being quite a difficult discussion for some who had hoped that they could stave off chemotherapy.

Pages